vs
Side-by-side financial comparison of Astrana Health, Inc. (ASTH) and Magnera Corp (MAGN). Click either name above to swap in a different company.
Astrana Health, Inc. is the larger business by last-quarter revenue ($950.5M vs $792.0M, roughly 1.2× Magnera Corp). Astrana Health, Inc. runs the higher net margin — 0.7% vs -4.3%, a 5.0% gap on every dollar of revenue. On growth, Astrana Health, Inc. posted the faster year-over-year revenue change (42.9% vs 12.8%). Astrana Health, Inc. produced more free cash flow last quarter ($-6.0M vs $-13.0M). Over the past eight quarters, Magnera Corp's revenue compounded faster (54.9% CAGR vs 53.3%).
Astrana Health, Inc. is a U.S.-based value-based healthcare services provider that primarily serves Medicare-eligible senior populations across the United States. It offers in-home primary care, chronic disease management, and care coordination services, aiming to improve patient health outcomes and reduce unnecessary medical costs.
ASTH vs MAGN — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $950.5M | $792.0M |
| Net Profit | $6.6M | $-34.0M |
| Gross Margin | — | 12.2% |
| Operating Margin | 1.9% | 1.8% |
| Net Margin | 0.7% | -4.3% |
| Revenue YoY | 42.9% | 12.8% |
| Net Profit YoY | 184.4% | 43.3% |
| EPS (diluted) | $0.12 | $-0.95 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $950.5M | $792.0M | ||
| Q3 25 | $956.0M | — | ||
| Q2 25 | $654.8M | $839.0M | ||
| Q1 25 | $620.4M | $824.0M | ||
| Q4 24 | $665.2M | $702.0M | ||
| Q3 24 | $478.7M | $332.1M | ||
| Q2 24 | $486.3M | $556.0M | ||
| Q1 24 | $404.4M | $558.0M |
| Q4 25 | $6.6M | $-34.0M | ||
| Q3 25 | $373.0K | — | ||
| Q2 25 | $9.4M | $-18.0M | ||
| Q1 25 | $6.7M | $-41.0M | ||
| Q4 24 | $-7.8M | $-60.0M | ||
| Q3 24 | $16.1M | $-15.2M | ||
| Q2 24 | $19.2M | $19.0M | ||
| Q1 24 | $14.8M | $14.0M |
| Q4 25 | — | 12.2% | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 10.7% | ||
| Q1 25 | — | 10.7% | ||
| Q4 24 | — | 10.1% | ||
| Q3 24 | — | 10.7% | ||
| Q2 24 | — | 6.6% | ||
| Q1 24 | — | 6.2% |
| Q4 25 | 1.9% | 1.8% | ||
| Q3 25 | 2.0% | — | ||
| Q2 25 | 3.1% | 1.5% | ||
| Q1 25 | 3.3% | 0.5% | ||
| Q4 24 | 0.1% | -3.1% | ||
| Q3 24 | 5.9% | 0.9% | ||
| Q2 24 | 6.2% | 3.1% | ||
| Q1 24 | 7.5% | 3.8% |
| Q4 25 | 0.7% | -4.3% | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | 1.4% | -2.1% | ||
| Q1 25 | 1.1% | -5.0% | ||
| Q4 24 | -1.2% | -8.5% | ||
| Q3 24 | 3.4% | -4.6% | ||
| Q2 24 | 3.9% | 3.4% | ||
| Q1 24 | 3.7% | 2.5% |
| Q4 25 | $0.12 | $-0.95 | ||
| Q3 25 | $0.01 | — | ||
| Q2 25 | $0.19 | $-0.51 | ||
| Q1 25 | $0.14 | $-1.15 | ||
| Q4 24 | $-0.14 | $-1.69 | ||
| Q3 24 | $0.33 | $-0.33 | ||
| Q2 24 | $0.40 | $0.60 | ||
| Q1 24 | $0.31 | $0.44 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $429.5M | $264.0M |
| Total DebtLower is stronger | — | $1.9B |
| Stockholders' EquityBook value | $779.3M | $1.0B |
| Total Assets | $2.2B | $3.9B |
| Debt / EquityLower = less leverage | — | 1.86× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $429.5M | $264.0M | ||
| Q3 25 | $463.4M | — | ||
| Q2 25 | $342.1M | $276.0M | ||
| Q1 25 | $260.9M | $282.0M | ||
| Q4 24 | $290.8M | $215.0M | ||
| Q3 24 | $350.3M | $230.0M | ||
| Q2 24 | $327.7M | $33.9M | ||
| Q1 24 | $337.3M | $30.2M |
| Q4 25 | — | $1.9B | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $2.0B | ||
| Q1 25 | — | $2.0B | ||
| Q4 24 | — | $2.0B | ||
| Q3 24 | — | $2.0B | ||
| Q2 24 | — | $877.4M | ||
| Q1 24 | — | $884.7M |
| Q4 25 | $779.3M | $1.0B | ||
| Q3 25 | $775.5M | — | ||
| Q2 25 | $765.5M | $1.1B | ||
| Q1 25 | $745.4M | $1.1B | ||
| Q4 24 | $712.7M | $1.1B | ||
| Q3 24 | $704.6M | $2.1B | ||
| Q2 24 | $678.9M | $2.4B | ||
| Q1 24 | $653.5M | $2.4B |
| Q4 25 | $2.2B | $3.9B | ||
| Q3 25 | $2.2B | — | ||
| Q2 25 | $1.4B | $4.1B | ||
| Q1 25 | $1.3B | $4.1B | ||
| Q4 24 | $1.4B | $4.0B | ||
| Q3 24 | $1.3B | $2.8B | ||
| Q2 24 | $1.3B | $1.5B | ||
| Q1 24 | $1.2B | $1.5B |
| Q4 25 | — | 1.86× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 1.77× | ||
| Q1 25 | — | 1.83× | ||
| Q4 24 | — | 1.80× | ||
| Q3 24 | — | 0.91× | ||
| Q2 24 | — | 0.37× | ||
| Q1 24 | — | 0.36× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-2.9M | $2.0M |
| Free Cash FlowOCF − Capex | $-6.0M | $-13.0M |
| FCF MarginFCF / Revenue | -0.6% | -1.6% |
| Capex IntensityCapex / Revenue | 0.3% | 1.9% |
| Cash ConversionOCF / Net Profit | -0.44× | — |
| TTM Free Cash FlowTrailing 4 quarters | $104.5M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-2.9M | $2.0M | ||
| Q3 25 | $10.0M | — | ||
| Q2 25 | $90.9M | $0 | ||
| Q1 25 | $16.6M | $65.0M | ||
| Q4 24 | $-10.9M | $-58.0M | ||
| Q3 24 | $34.0M | $12.2M | ||
| Q2 24 | $23.2M | $38.0M | ||
| Q1 24 | $6.0M | $20.0M |
| Q4 25 | $-6.0M | $-13.0M | ||
| Q3 25 | $7.4M | — | ||
| Q2 25 | $89.5M | — | ||
| Q1 25 | $13.6M | $42.0M | ||
| Q4 24 | $-13.5M | $-74.0M | ||
| Q3 24 | $31.7M | $3.6M | ||
| Q2 24 | $20.4M | $23.0M | ||
| Q1 24 | $5.6M | $12.5M |
| Q4 25 | -0.6% | -1.6% | ||
| Q3 25 | 0.8% | — | ||
| Q2 25 | 13.7% | — | ||
| Q1 25 | 2.2% | 5.1% | ||
| Q4 24 | -2.0% | -10.5% | ||
| Q3 24 | 6.6% | 1.1% | ||
| Q2 24 | 4.2% | 4.1% | ||
| Q1 24 | 1.4% | 2.2% |
| Q4 25 | 0.3% | 1.9% | ||
| Q3 25 | 0.3% | — | ||
| Q2 25 | 0.2% | 1.5% | ||
| Q1 25 | 0.5% | 2.8% | ||
| Q4 24 | 0.4% | 2.3% | ||
| Q3 24 | 0.5% | 2.6% | ||
| Q2 24 | 0.6% | 2.7% | ||
| Q1 24 | 0.1% | 1.3% |
| Q4 25 | -0.44× | — | ||
| Q3 25 | 26.69× | — | ||
| Q2 25 | 9.65× | — | ||
| Q1 25 | 2.48× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.11× | — | ||
| Q2 24 | 1.21× | 2.00× | ||
| Q1 24 | 0.40× | 1.43× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ASTH
| Medicare | $542.4M | 57% |
| Commercial | $99.1M | 10% |
| Care Delivery | $92.1M | 10% |
| Care Enablement | $78.9M | 8% |
| Other Third Parties | $58.0M | 6% |
| Health Care Patient Service | $39.8M | 4% |
| Health Care Other | $25.5M | 3% |
| Other | $12.1M | 1% |
| Management Service | $10.3M | 1% |
MAGN
| Other | $451.0M | 57% |
| United States And Canada | $341.0M | 43% |
